Invention Grant
- Patent Title: Sensitizer-peptide conjugate
-
Application No.: US16625664Application Date: 2018-06-25
-
Publication No.: US11712473B2Publication Date: 2023-08-01
- Inventor: John Francis Callan , Bridgeen Callan , Anthony Patrick McHale
- Applicant: UNIVERSITY OF ULSTER
- Applicant Address: GB Coleraine
- Assignee: UNIVERSITY OF ULSTER
- Current Assignee: UNIVERSITY OF ULSTER
- Current Assignee Address: GB County Londonderry
- Agency: Hamilton, Brook, Smith & Reynolds, P.C.
- Priority: GB 10097 2017.06.23
- International Application: PCT/EP2018/066982 2018.06.25
- International Announcement: WO2018/234586A 2018.12.27
- Date entered country: 2019-12-20
- Main IPC: A61K41/00
- IPC: A61K41/00 ; C07K7/06
Abstract:
The present invention relates to a sensitizer-peptide conjugate for use in the treatment of cancer. In particular, the present invention relates to a sensitizer-peptide conjugate for use in the treatment of melanoma. The use of such sensitizer-peptide conjugate in photodynamic therapy or sonodynamic therapy is also disclosed. According to the present invention, there is provided a sensitizer-peptide conjugate for use in the treatment of cancer; wherein the sensitizer-peptide conjugate comprises at least one sensitizer and at least one peptide.
Public/Granted literature
- US20210154297A1 A SENSITIZER - PEPTIDE CONJUGATE Public/Granted day:2021-05-27
Information query
